Stocktoria
Elevance Health, Inc. ELV
Elevance Health, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.1B | $177.0B | $171.3B | $156.6B | $138.6B | $121.9B | $104.2B | $92.1B | $90.0B | $84.9B |
| SG&A expense | $21.0B | $20.0B | $20.1B | $17.7B | $15.9B | $17.4B | $13.4B | $14.0B | $12.7B | $12.6B |
| Operating income | $7.2B | $7.9B | $8.5B | $8.3B | $7.6B | $6.4B | $6.0B | $5.4B | $4.2B | $4.8B |
| Interest expense | — | — | $1.0B | $851.0M | $798.0M | $784.0M | $746.0M | $753.0M | $739.0M | $723.0M |
| Income tax | $1.0B | $1.9B | $1.7B | $1.7B | $1.8B | $1.7B | $1.2B | $1.3B | $121.0M | $2.1B |
| Net income | $5.7B | $6.0B | $6.0B | $5.9B | $6.2B | $4.6B | $4.8B | $3.8B | $3.8B | $2.5B |
| EPS (diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 |
| Operating cash flow | $4.3B | $5.8B | $8.1B | $8.4B | $8.4B | $10.7B | $6.1B | $3.8B | $4.2B | $3.3B |
| Free cash flow | $3.2B | $4.6B | $6.8B | $7.2B | $7.3B | $9.7B | $5.0B | $2.6B | $3.4B | $2.7B |
| Cash & equivalents | $9.5B | $8.3B | $6.5B | $7.4B | $4.9B | $5.7B | $4.9B | $3.9B | $3.6B | $4.1B |
| Total assets | $121.5B | $116.9B | $108.9B | $102.8B | $97.5B | $86.6B | $77.5B | $71.6B | $70.5B | $65.1B |
| Total liabilities | $77.5B | $75.5B | $69.5B | $66.4B | $61.3B | $53.4B | $45.7B | $43.0B | $44.0B | $40.0B |
| Shareholders' equity | $44.0B | $41.4B | $39.4B | $36.3B | $36.1B | $33.2B | $31.7B | $28.6B | $26.5B | $25.1B |
Growth · year-over-year · Revenue CAGR 9.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +12.5% | +3.3% | +9.4% | +13.0% | +13.8% | +16.9% | +13.1% | +2.3% | +6.1% | +7.2% |
| Net income growth | -5.3% | -0.1% | +1.6% | -4.3% | +34.7% | -4.9% | +28.2% | -2.4% | +55.6% | -3.5% |
| EPS growth | -1.8% | +1.8% | +3.9% | -2.7% | +38.8% | -2.7% | +30.2% | -1.1% | +55.8% | -1.8% |
| Free cash flow growth | -30.3% | -32.7% | -6.7% | -0.4% | -24.7% | +94.0% | +90.3% | -22.8% | +26.4% | -24.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.